Delivery Order SPE2DB20D3103-SPE2DB24FM2M1

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $6.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Cosentyx 300 mg doses in syringes. The firm-fixed-price delivery order, valued at $26,746.11, has an ultimate completion date of December 20, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FR62K) worth $15,034.37 for the pharmaceutical product Cosentyx. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 15, 2023. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a range of pharmaceutical products and medical supplies. The contract, valued at $16,754.91, covers the delivery of Cosentyx 300 mg dose-2 pens and has an ultimate completion date of April 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Cosentyx, a specialty medication, to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The award, valued at $59,120.51, is a firm fixed-price delivery order with a completion date of February 6, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp, as the prime contractor, has an extensive history of...
The federal contract award is for the delivery of pharmaceutical products, specifically the medication Cosentyx 300 mg, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on October 18, 2023, with a ceiling value of $19,055.23 and an ultimate completion date of October 19, 2023. The contract is a delivery order under a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,175.26 firm-fixed-price delivery order is for the medication Cosentyx 300 mg, with a period of performance through November 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order, valued at $11,558.62, is for the pharmaceutical product Cosentyx (300mg dose) to support Department of Defense and veterans' healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $9,280.09, is for the delivery of the specialty drug Cosentyx (300mg dose) and is a firm fixed-price delivery order contract. The contract has an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of Cosentyx 300 mg doses to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The contract, valued at $11,704.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period ending on December 6, 2023 and is structured as a firm-fixed-price delivery order. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $9,169.68, is for the delivery of Cosentyx 300 mg dose-2 pen syringes. This is a firm fixed-price delivery order contract with a completion date of February 8, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM2M1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,087.80, is for the delivery of the pharmaceutical product Cosentyx (300mg dose) and has a completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 2/27/25, 12:45 PM